Ansornitinib

Details

Stereochemistry	ACHIRAL
Molecular Formula	C30H32N6O4
Molecular Weight	540.6129
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

COC(=O)C1=CC=C2C(NC(=O)\C2=C(/NC3=CC=C(C=C3)N(C)C(=O)CN4CCN(C)CC4)C5=CC=CC=C5)=N1

InChI

InChIKey=OABALTWKAJWHEA-RQZHXJHFSA-N

InChI=1S/C30H32N6O4/c1-34-15-17-36(18-16-34)19-25(37)35(2)22-11-9-21(10-12-22)31-27(20-7-5-4-6-8-20)26-23-13-14-24(30(39)40-3)32-28(23)33-29(26)38/h4-14,31H,15-19H2,1-3H3,(H,32,33,38)/b27-26-

HIDE SMILES / InChI

Molecular Formula	C30H32N6O4
Molecular Weight	540.6129
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	1
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 18:31:28 GMT 2023` Edited by `admin` on `Sat Dec 16 18:31:28 GMT 2023`
Record UNII	LHC4W5LJH4
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Ansornitinib

Official Name

English

methyl (3Z)-3-[{4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]anilino}(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-6-carboxylate

Systematic Name

English

1H-PYRROLO(2,3-B)PYRIDINE-6-CARBOXYLIC ACID, 2,3-DIHYDRO-3-(((4-(METHYL(2-(4-METHYL-1-PIPERAZINYL)ACETYL)AMINO)PHENYL)AMINO)PHENYLMETHYLENE)-2-OXO-, METHYL ESTER, (3Z)-

Systematic Name

English

ansornitinib [INN]

Common Name

English

Code System Code Type Description

SMS_ID

300000039911

Created by admin on Sat Dec 16 18:31:28 GMT 2023 , Edited by admin on Sat Dec 16 18:31:28 GMT 2023

PRIMARY

INN

12287

Created by admin on Sat Dec 16 18:31:28 GMT 2023 , Edited by admin on Sat Dec 16 18:31:28 GMT 2023

PRIMARY

FDA UNII

LHC4W5LJH4

Created by admin on Sat Dec 16 18:31:28 GMT 2023 , Edited by admin on Sat Dec 16 18:31:28 GMT 2023

PRIMARY

CAS

1448874-96-1

Created by admin on Sat Dec 16 18:31:28 GMT 2023 , Edited by admin on Sat Dec 16 18:31:28 GMT 2023

PRIMARY

Related Record Type Details


					LHC4W5LJH4

Ansornitinib

ACTIVE MOIETY

Interaction Type:

IN-VITRO

Amount: